New catheter delivers drug directly to leg arteries to prevent reblockage
NCT ID NCT00821028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether delivering the drug paclitaxel directly to the leg artery during angioplasty could reduce the chance of the artery narrowing again. 27 adults with leg pain from blocked arteries took part. The main goal was to see if the drug helped keep the artery open longer than standard treatment alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOPLASTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73126, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
- Ozone therapy put to the test: could it harm your eyes?
- Biodegradable artery graft could revolutionize leg bypass surgery
- Could an arthritis drug shield heart and kidneys in metabolic syndrome?
- Could a green tea compound prevent second heart attacks?